Latest Commercialization News

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.

Resolution Minerals Ltd has responded to an ASX price query following a significant jump in its share price and trading volume, confirming no undisclosed material information. The company attributes the surge to sector-wide momentum and recent diplomatic engagements.

Hazer Group has received a $4.58 million R&D tax incentive refund for FY25, reinforcing its financial position as it advances its methane pyrolysis technology towards commercialisation.

Stockland has reaffirmed its FY26 financial guidance following a strong first quarter marked by solid sales in masterplanned and land lease communities and positive leasing outcomes across its commercial portfolio.

Iron Road Ltd progresses its Central Eyre Iron Project and Mulgathing heavy mineral sands exploration despite subdued iron ore investment and volatile energy costs. Strategic land options secured at Cape Hardy signal potential green hydrogen collaboration.

Nanoveu Limited showcased its cutting-edge EMASS semiconductor technology at the Ignite Investment Summit in Hong Kong, highlighting a new ultra-low-power AI chip designed to revolutionize edge computing across multiple industries.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

Provaris Energy has launched a Robotics Innovation Centre in Norway, marking a pivotal step in fabricating and testing advanced hydrogen and liquid CO2 storage tanks. The initiative aims to accelerate prototype completion and commercial scalability by early 2026.

Cannindah Resources has reported impressive trenching results at its Mt Cannindah project, revealing high-grade copper-gold mineralisation and new porphyry targets. These findings set the stage for imminent drilling campaigns aimed at unlocking further value.

Blue Star Helium Limited is advancing its Galactica helium project in Colorado, aiming for initial commercial production by December 2025, supported by a recent A$4.5 million equity raise.

Bougainville Copper Limited remains inactive in production but advances talks with international mining firms to revive the long-dormant Panguna Project, backed by the Autonomous Bougainville Government.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.